L22 Ribosomal Protein and Effect of Its Mutation on Ribosome Resistance to Erythromycin
- 12 September 2002
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 322 (3) , 635-644
- https://doi.org/10.1016/s0022-2836(02)00772-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteriaNature, 2001
- Macrolide–ketolide inhibition of MLS‐resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNAMolecular Microbiology, 2000
- Sites of interaction of streptogramin A and B antibiotics in the peptidyl transferase loop of 23 S rRNA and the synergism of their inhibitory mechanisms 1 1Edited by D. E. DraperJournal of Molecular Biology, 1999
- The macrolide–ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNAMolecular Microbiology, 1999
- A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centreMolecular Microbiology, 1999
- Ribosomal protein L22 fromThermus thermophilus: sequencing overexpression and crystallisationFEBS Letters, 1995
- Fine Structure of the Peptidyl Transferase Centre on 23 S-like rRNAs Deduced from Chemical Probing of Antibiotic-Ribosome ComplexesJournal of Molecular Biology, 1995
- Erythromycin, lincosamides, peptidyl-tRNA dissociation, and ribosome editingMolecular Genetics and Genomics, 1994
- Functional interactions within 23S rRNA involving the peptidyltransferase centerJournal of Bacteriology, 1992
- Erythromycin, carbomycin, and spiramycin inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomesAntimicrobial Agents and Chemotherapy, 1982